Dr Stephen Kopecky from Mayo Clinic talks about nonpharmacologic and pharmacologic options for preventing atrial fibrillation.

Many patients already struggle to afford their necessary prescriptions, but the prices of hundreds of drugs — including some generics — are set to rise even higher this year. In a podcast interview with Consultant360, Dr David Nash, founding dean of the Jefferson College of Population Health and chair of the 19th Population Health Colloquium, discusses the patient- and provider-level impact of rising pharmaceutical prices, and outlines steps he says are needed to truly address the issue. For more, visit www.consultant360.com.

Many patients already struggle to afford their necessary prescriptions, but the prices of hundreds of drugs — including some generics — are set to rise even higher this year. In a podcast interview with Consultant360, Dr David Nash, founding dean of the Jefferson College of Population Health and chair of the 19th Population Health Colloquium, discusses the patient- and provider-level impact of rising pharmaceutical prices, and outlines steps he says are needed to truly address the issue. For more, visit www.consultant360.com.

Many patients already struggle to afford their necessary prescriptions, but the prices of hundreds of drugs — including some generics — are set to rise even higher this year. In a podcast interview with Consultant360, Dr David Nash, founding dean of the Jefferson College of Population Health and chair of the 19th Population Health Colloquium, discusses the patient- and provider-level impact of rising pharmaceutical prices, and outlines steps he says are needed to truly address the issue. For more, visit www.consultant360.com.

Dr Emily Johnson from Johns Hopkins University School of Medicine talks about her research on late-onset epilepsy, the midlife risk factors that may contribute to late-onset epilepsy, and more.

Dr Emily Johnson from Johns Hopkins University School of Medicine talks about her research on late-onset epilepsy, the midlife risk factors that may contribute to late-onset epilepsy, and more.

Dr Emily Johnson from Johns Hopkins University School of Medicine talks about her research on late-onset epilepsy, the midlife risk factors that may contribute to late-onset epilepsy, and more.

In part 1 of this series, board-certified nurse practitioner Lucia Novak, director of Riverside Diabetes Center, defines clinical inertia and outlines patient- and practitioner-level factors that may impede appropriate management of your patients’ diabetes. For more, visit www.consultant360.com.

In part 1 of this series, board-certified nurse practitioner Lucia Novak, director of Riverside Diabetes Center, defines clinical inertia and outlines patient- and practitioner-level factors that may impede appropriate management of your patients’ diabetes. For more, visit www.consultant360.com.

In part 1 of this series, board-certified nurse practitioner Lucia Novak, director of Riverside Diabetes Center, defines clinical inertia and outlines patient- and practitioner-level factors that may impede appropriate management of your patients’ diabetes. For more, visit www.consultant360.com.